Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (20)

2024

  1. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study

    eClinicalMedicine, Vol. 74

2023

  1. Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study

    Clinical Transplantation, Vol. 37, Núm. 12

2022

  1. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

2021

  1. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884

  2. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Influence of donor liver CYP3A4∗20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients

    Pharmacogenetics and Genomics, Vol. 28, Núm. 2, pp. 41-48

  3. VI consensus document by the Spanish Liver Transplantation Society

    Gastroenterologia y Hepatologia, Vol. 41, Núm. 6, pp. 406-421

  4. VI consensus document by the Spanish Liver Transplantation Society

    Cirugia Espanola, Vol. 96, Núm. 6, pp. 326-341

2017

  1. Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

    Transplant International, Vol. 30, Núm. 10, pp. 1041-1050

  2. Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study

    World Journal of Gastroenterology, Vol. 23, Núm. 41, pp. 7459-7469

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

    World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174

  2. Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

    Genes and Immunity, Vol. 16, Núm. 5, pp. 297-300

  3. Perfil clínico y seguimiento de los pacientes con hepatitis C crónica en hospitales españoles: Estudio disHCovery

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 145-153

  4. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2014

  1. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C

    Annals of Hepatology, Vol. 13, Núm. 4, pp. 356-363

2013

  1. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in caucasian spanish liver transplant patients

    Journal of Clinical Pharmacology, Vol. 53, Núm. 11, pp. 1146-1154

2009

  1. The Spanish HIV BioBank: A model of cooperative HIV research

    Retrovirology, Vol. 6

1994

  1. Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers

    Journal of Hepatology, Vol. 21, Núm. 3, pp. 353-360